Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pulmonx Corp

3.34
+0.02500.75%
Post-market: 3.340.00000.00%16:11 EDT
Volume:254.37K
Turnover:843.32K
Market Cap:134.46M
PE:-2.31
High:3.41
Open:3.32
Low:3.20
Close:3.32
Loading ...

Pulmonx Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
01 May

Pulmonx reports Q1 EPS (36c), consensus (40c)

TIPRANKS
·
01 May

Pulmonx backs FY25 revenue view $96M-$98M, consensus $96.98M

TIPRANKS
·
01 May

Pulmonx Q1 EPS $(0.36) Beats $(0.41) Estimate, Sales $22.54M Beat $22.03M Estimate

Benzinga
·
01 May

BRIEF-Pulmonx Q1 EPS USD -0.36

Reuters
·
01 May

Pulmonx Reports First Quarter 2025 Financial Results

GlobeNewswire
·
01 May

Pulmonx Corp expected to post a loss of 40 cents a share - Earnings Preview

Reuters
·
29 Apr

Pulmonx to Report First Quarter 2025 Financial Results on April 30, 2025

GlobeNewswire
·
17 Apr

IMDELLTRA® DEMONSTRATED SUPERIOR OVERALL SURVIVAL IN SMALL CELL LUNG CANCER

PR Newswire
·
11 Apr

Pulmonx Initiated at Buy by D. Boral Capital

Dow Jones
·
10 Mar

Lake Street Keeps Their Buy Rating on Pulmonx (LUNG)

TIPRANKS
·
07 Mar

EDAP Appoints Glen French to Board of Directors

GlobeNewswire
·
03 Mar

Pulmonx Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
28 Feb

Pulmonx management to meet virtually with Lake Street

TIPRANKS
·
28 Feb

Pulmonx Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
21 Feb

Pulmonx (LUNG) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
20 Feb

Wells Fargo Reaffirms Their Hold Rating on Pulmonx (LUNG)

TIPRANKS
·
20 Feb

Strong Financial Performance and Strategic Initiatives Drive Pulmonx’s Buy Rating

TIPRANKS
·
20 Feb

Pulmonx Corp (LUNG) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Financial ...

GuruFocus.com
·
20 Feb

Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
20 Feb